Abbott to acquire Piramal Healthcare's Healthcare Solutions branded generics business for $2.2B upfront + $400M annual installments 2011-2014. Made Abbott #1 pharma in India. Closed September 8, 2010.
Did it work? Outcome assessment
Strategic verdict
Partially Achieved
Financial impact
Dilutive
Assessment window: 10yr post-close.
Key facts
AnnouncedMay 21, 2010
ClosedSep 08, 2010
Deal value$3.7B
Deal typeAsset Purchase
Therapeutic areaBranded generics across multiple categories
IndicationsBranded generics across multiple categories